Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-66.17	32.93	97.33
Graham Fair Price	13.21	38.04	33.60
PEG	-39.45	0.35	-0.58
Price/Book	-11.69	1.38	1.56
Price/Cash Flow	386.51	85.98	17.67
Prices/Earnings	-34.15	10.97	16.66
Price/Sales	-10.60	1.46	1.64
Price/FCF	386.51	85.98	17.67
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	79.60	0.08	0.05
Operating Margin	509.99	0.04	< 0.005
ROA	28.56	0.01	0.01
ROE	0.02	0.03	34.10
ROIC	< 0.005	0.02	524.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.18	0.01	1644.87
Dividends QOQ	0.01	0.09	527.41
EBIT QOQ	-0.85	4.80	466.91
EPS QOQ	-0.29	0.31	8.75
FCF QOQ	2.87	-0.83	-71.20
Revenue QOQ	0.06	-0.05	-16.66
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	49.08	52.26	6.48
Days Sales Outstanding (DSO)	25.43	26.64	4.75
Inventory Turnover	1.83	1.72	-6.08
Debt/Capitalization	0.26	0.31	16.14
Quick Ratio	1.02	0.95	-7.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.30	45.26	-2.24
Cash	24.21	23.83	-1.55
Capex	-0.84	-0.64	24.08
Free Cash Flow	4.09	0.73	-82.25
Revenue	44.10	42.58	-3.43
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.60	1.47	-7.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.78	5.52	-43.56
Naive Interpretation	Member

06 - Financial Health · Weak

Rating